CTOR Earnings CITIUS ONCOLOGY, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q2 2026 | 2026-03-31 | -0.34 | 2026-05-15 | 10-Q |
| Q1 2026 | 2025-12-31 | -0.06 | 2026-02-13 | 10-Q |
| FY 2025 | 2025-09-30 | -0.34 | 2025-12-23 | 10-K |
| Q3 2025 | 2025-06-30 | -0.28 | 2025-08-12 | 10-Q |
| Q2 2026 | 2025-03-31 | -0.20 | 2026-05-15 | 10-Q |
| Q1 2026 | 2024-12-31 | -0.09 | 2026-02-13 | 10-Q |
| FY 2025 | 2024-09-30 | -0.31 | 2025-12-23 | 10-K |
| Q3 2025 | 2024-06-30 | -0.21 | 2025-08-12 | 10-Q |
| Q2 2025 | 2024-03-31 | -0.14 | 2025-05-14 | 10-Q |
| Q1 2025 | 2023-12-31 | -0.07 | 2025-02-14 | 10-Q |
| FY 2024 | 2023-09-30 | -0.19 | 2024-12-27 | 10-K |
| Q2 2024 | 2023-06-30 | 0.14 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.07 | 2024-05-20 | 10-Q |
| FY 2023 | 2022-12-31 | 0.12 | 2024-04-16 | 10-K |
| Q3 2023 | 2022-09-30 | 0.00 | 2023-11-20 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.00 | 2023-08-16 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.